Sam Ropp - 11 Apr 2023 Form 3 Insider Report for Singular Genomics Systems, Inc. (OMIC)

Role
Chief Commercial Officer
Signature
/s/ Sam Ropp
Issuer symbol
OMIC
Transactions as of
11 Apr 2023
Transactions value $
$0
Form type
3
Filing time
20 Apr 2023, 18:38:59 UTC
Next filing
20 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OMIC Employee Stock Option (Right to Buy) 11 Apr 2023 Common Stock 275K $4.23 Direct F1
holding OMIC Employee Stock Option (Right to Buy) 11 Apr 2023 Common Stock 134K $1.28 Direct F2
holding OMIC Restricted Stock Unit 11 Apr 2023 Common Stock 67K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the the option shares vest and become exercisable on July 5, 2023, the remainder of the option shares vest in 36 equal monthly installments thereafter, beginning on August 5, 2023.
F2 The option shares vest and become exercisable in 48 equal monthly installments measured from March 15, 2023.
F3 The Restricted Stock Units vest in 16 equal quarterly installments measured from March 15, 2023.
F4 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's Common Stock.